New dihydropyridine compound (GYKI-46 544) with bradycardiac and vasodilatory effects
Rabloczky, G.; Jaszlits, L.; Bódi, I.; Szilágyi, G.; Jednákovits, A.; Kovács, A.; Horváth, E.; Bozó, E.
Acta Physiologica Hungarica 75 Suppl: 239-240
1990
ISSN/ISBN: 0231-424X PMID: 2371876 Document Number: 364102
Document emailed within 1 workday
Related Documents
Király, I.; Borsy, J.; Tapfer, M.; Losonczy, S.; Rásky, K.; Toldy, L.; Tóth, I. 1990: Preclinical studies with compound GYKI-22441, a new long-acting neuroleptic phenothiazine Acta Physiologica Hungarica 75 Suppl: 171-172DasGupta, P.; Broadhurst, P.; Lahiri, A. 1991: The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure Journal of Cardiovascular Pharmacology 18(Suppl 4): S12-S16
Takenaka, T.; Usuda, S.; Nomura, T.; Maeno, H.; Sado, T. 1976: Vasodilator profile of a new 1,4-dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ethyl ester 5-methyl ester hydrochloride (YC-93) Arzneimittel-Forschung 26(12): 2172-2178
Gross, R.; Kayser, M.; Schramm, M.; Taniel, R.; Thomas, G. 1985: Cardiovascular effects of the calcium-agonistic dihydropyridine BAY K 8644 in conscious dogs Archives Internationales de Pharmacodynamie et de Therapie 277(2): 203-216
Kazda, S.; Garthoff, B.; Krause, H.P.; Schlossmann, K. 1982: Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments Arzneimittel-Forschung 32(4): 331-338
Karpova, M.N.; Pankov, O.I.; Germane, S.K.; Klusha, V.E.; Duburs, G. 1993: The antiepileptic effects of the combined action of the new 1,4-dihydropyridine derivative glutapyrone with sodium valproate and phenobarbital Biulleten' Eksperimental'noi Biologii i Meditsiny 116(12): 586-588
Galletti, F.; Strazzullo, P.; Barba, G.; Ferrara, I.; Iacone, R.; Stinga, F.; Mancini, M. 1996: Antihypertensive and renal effects of acute and chronic therapy with a dihydropyridine Ca-antagonist in patients with different salt sensitivity Journal of Cardiovascular Pharmacology 27(4): 578-582
Koch, H.J. 1998: Effects of the dihydropyridine calcium antagonist nimodipine on the firing rate of cat visual neurons after systemic administration Polish Journal of Pharmacology 50(1): 39-45
Yamagishi, S.; Takeuchi, M.; Inoue, H. 2005: Renoprotective effects of azelnidipine, a dihydropyridine-based calcium antagonist in advanced glycation end product (AGE)-injected rats International Journal of Tissue Reactions 27(3): 137-143
Liu, D.Q.; Zhou, S.S.; Zhao, D.H.; Sheng, B.H. 1993: Effects of furyl-dihydropyridine on action potential ventricular myocardium of rabbit in vivo and isolated guinea pig left atrium in vitro Zhongguo Yao Li Xue Bao 14(2): 164-167
1982: Clinical therapeutic effects of compound "Xiaolijun" in treating acute and chronic bacillary dysentery and in its bacillicidal effects in vitro Zhonghua Yi Xue Za Zhi 62(6): 354-357
Fischer, G.; Schneider, W.; Krumpl, G.; Grohs, J.G.; Raberger, G. 1989: Effects of niguldipine, a new dihydropyridine calcium antagonist, on regional blood flow, cardiac performance and myocardial metabolism in anaesthetized open-chest dogs Archives Internationales de Pharmacodynamie et de Therapie 298: 96-107
Vitale, P.; Di Bonito, P.; Caso, P.; Jacono, A. 1980: Digitalis poisoning in atrial fibrillation. the nature and origin of bradycardiac QRS complexes Minerva Cardioangiologica 28(7-8): 481-488
Kohler, H.P. 1996: What is your diagnosis? Ventricular tachycardia with capture beats in bradycardiac atrial fibrillation Praxis 85(50): 1599-1600
Berzétei, I.P.; Bagdy, E.; Hardy, M.; Borsy, J. 1985: The effect of GYKI-32 887 on dopamine (D2) and serotonin (5-HT1 and 5-HT2) receptors Polish Journal of Pharmacology and Pharmacy 37(3): 237-242
Wójcik, A.; Burek, G.; Kowalczyk, A. 1989: Toxic-dynamics of lead compound and zinc compound in the evaluation of experimental animal behavior Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 44: 71-76
Eyüboğlu, H.; Akcasu, A. 1979: The effects of compound 48/80 on the fibrinolytic activity of dogs Thrombosis and Haemostasis 41(2): 384-391
Bajaj, U.K.; Sharma, V.N. 1977: Sympathomimetic effects of a newly synthesised compound (SBS-I) Indian Journal of Medical Research 65(3): 441-446
Sarin, P.S.; Gallo, R.C.; Scheer, D.I.; Crews, F.; Lippa, A.S. 1985: Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro New England Journal of Medicine 313(20): 1289-1290
Nilius, B.; Schumann, M. 1985: Inotropic effects of the antiarrhythmic compound Bonnecor (AWD 19-166, GS 015) Die Pharmazie 40(12): 854